Follow politician tradesSenate and House disclosures, the day they post.+
STOCK Act filings from Senate eFD and the House Clerk become a delayed, source-cited review board. Your agent proposes watchlist adds or a proportional review. You approve each one.
Spot insider buyingForm 4: executives buying their own stock.+
Officer and director purchases from SEC EDGAR, clustered so a lone routine grant looks different from three executives buying the same week.
Track whale funds13F: what big funds added or dumped.+
Quarterly 13F position changes for managers you pick, with size, direction, and a reminder of the 45-day filing lag so stale data never masquerades as news.
Federal contract winsWho just won government money.+
Award announcements from official procurement data, mapped to tickers you follow, with award size and agency attached.
FDA decisionsApprovals and advisory dates.+
Approval actions and committee calendars for the biotech names on your watchlist, from FDA.gov, journaled with dates and links.
Clinical trial movesStarts, halts, and results.+
ClinicalTrials.gov status changes for companies you track, so a quietly halted phase 3 shows up in your morning check.
Patent filingsWhat companies are quietly building.+
New USPTO applications and grants by companies you watch, summarized into a research note with the filing linked.
Regulatory docketsRules that move sectors.+
Proposed rules and comment deadlines from regulations.gov that touch the sectors you hold, flagged before they become headlines.
Eight of the 11 research modules in the $99 bundle. Official sources only, every output cited, none of it advice. See all modules →